Endoscopic Variceal Ligation Versus Endoscopic Injection Sclerotherapy: Comparison of Hepatic and Renal Function

Nakase, Hiroshi; Kawasaki, Toshihiko; Komori, Hideshi; Sakatani, Noriaki; Sawai, Shigeaki; Chiba, Tsutomu
October 1996
American Journal of Gastroenterology;Oct1996, Vol. 91 Issue 10, p2170
Academic Journal
Objectives: The aim of the present study was to compare the safety of endoscopic variceal ligation (EVL) and endoscopic injection sclerotherapy (EIS) in terms of liver and kidney functions in patients with liver cirrhosis. Methods: Forty-four patients admitted to Takatsuki General Hospital between February 1991 and March 1993 with esophageal varices due to liver cirrhosis were randomly assigned to receive either EVL or EIS. Serum levels of AST, ALT, total bilirubin (T-bil), direct bilirubin (D-bil), prothrombin time (PT), hepaplastin test (HPT), antithrombin III (ATIII), creatinine (Cr), and blood urea nitrogen (BUN) were measured before and 24 h, 3 days, 7 days, and 14 days after both forms of therapy. Results: Significant elevations of serum T-bil, serum D-bil, and serum ALT and AST levels were observed in the EIS group but not in the EVL group. No significant increases of serum PT, HPT, ATIII, BUN, or Cr levels were observed after treatment in either group. Conclusion: EVL should be considered a first choice therapy for eradicating esophageal varices.


Related Articles

  • Transjugular Intrahepatic Portacaval Stent Shunt as a Rescue Treatment for Life-Threatening Variceal Bleeding in a Cirrhotic Patient with Severe Liver Failure. Bilodeau, M.; Rioux, L.; Willems, B.; Pomier-Layrargues, G. // American Journal of Gastroenterology;Mar1992, Vol. 87 Issue 3, p369 

    Variceal bleeding in cirrhotic patients with severe liver failure that is not controllable by endoscupic sclerotherapy is a life-threatening situation. We report the case of a patient with decompensated cirrhosis (Pugh class C) who bled repeatedly from gastric varices despite multiple sessions...

  • Announcements.  // American Journal of Gastroenterology;May1991, Vol. 86 Issue 5, p657 

    Presents information on conferences and other activities related to the field of gastroenterology to be held from June to September 1991. 11th Annual Advances in Gastroenteroloy; Cellular and Molecular Bases of Liver Cirrhosis; Mayo-European Course in Gastroenterology.

  • Nitrate Kinetics in Patients with Compensated Cirrhosis: Correlation with Hemodynamics. Shijo, Hiroshi; Yokoyama, Masanori; Ota, Kazuhiro; Kokawa, Hiroshi; Kubara, Katsuhiko; Kim, Tetsuhiro; Akiyoshi, Nobuo; Okumura, Makoto; Inoue, Kazuhide // American Journal of Gastroenterology;Oct1996, Vol. 91 Issue 10, p2190 

    Objectives: The serum nitrate concentration is known to be increased in patients with cirrhosis. This study was designed to determine the kinetics of nitrate in the splanchnic vascular areas and its relationship with hepatic hemodynamics in patients with compensated cirrhosis. Methods: We...

  • Mesenteric Venous Thrombosis as a Possible Complication of Endoscopic Sclerotherapy: A Report of Two Cases. Thatcher, Bryan S.; Sivak Jr., Michael V.; Ferguson, D. Roy; Petras, Robert E. // American Journal of Gastroenterology;Feb1986, Vol. 81 Issue 2, p126 

    Two cases of mesenteric venous thrombosis with bowel infarction occurring after endoscopic sclerotherapy are reported. In neither patient was the diagnosis suspected or recognized until the terminal phase of the illness. Clinicians should be aware of this possible association and complication of...

  • ACUTE PORTAL VEIN THROMBOSIS, SCLEROTHERAPY, AND VASOPRESSIN: RELATIONSHIPS AND IMPLICATIONS. Snady, Harry // American Journal of Gastroenterology;Dec1987, Vol. 82 Issue 12, p1292 

    Stresses the importance of case reports on three cirrhotics in whom acute portal vein thrombosis (PVT) occurred in apparent close temporal relationship to various treatments, including transfusion, vasopressin and sclerotherapy, given for an episode of variceal bleeding. Factors that cause PVT;...

  • An Endoscopic Injection With N-butyl-2- cyanoacrylate Used for Colonic Variceal Bleeding: A Case Report and Review of the Literature. Wen-Chi Chen; Ming-Chih Hou; Han-Chieh Lin; Full-Young Chang; Shou-Dong Lee // American Journal of Gastroenterology;Feb2000, Vol. 95 Issue 2, p540 

    We report a 64-yr-old patient with liver cirrhosis and bleeding esophageal varices that were obliterated by repeated endoscopic sclerotherapy. Eleven years later, he developed a massive, life-threatening rectosigmoid variceal hemorrhage. An endoscopic injection with N-butyl-2-cyanoacrylate...

  • Journal Scan. Welyczko, Nikki // Gastrointestinal Nursing;Oct2014, Vol. 12 Issue 8, p10 

    Abstracts of recently published nursing and health articles are presented including "Increased Service User and Carer Involvement Improves Endoscopy Nursing" by D. Martin, L. Hoy and K. N. Hoy and "Nurses Have a Vital Role to Play in Advanced Liver Disease" by A. Clements and L. Greenslade.

  • Combined ligation and sclerotherapy versus ligation alone for secondary prophylaxis of esophageal variceal bleeding: a meta-analysis. Singh, Pankaj; Pooran, Nakechand; Indaram, Anant; Bank, Simmy // American Journal of Gastroenterology;Mar2002, Vol. 97 Issue 3, p623 

    OBJECTIVES:Variceal ligation has been shown to be superior to sclerotherapy in prevention of rebleeding and improving survival in patients with cirrhosis. However, 25% of patients will rebleed before completion of treatment. A number of trials have compared the combination of ligation and...

  • Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Wong, G. L.-H.; Wong, V. W.-S.; Choi, P. C.-L.; Chan, A. W.-H.; Chim, A. M.-L.; Yiu, K. K.-L.; Chan, H.-Y.; Chan, F. K.-L.; Sung, J. J.-Y.; Chan, H. L.-Y. // Gut;Jan2009, Vol. 58 Issue 1, p111 

    Background: Metabolic syndrome is associated with non-alcoholic steatohepatitis and cryptogenic cirrhosis. Whether metabolic syndrome affects the severity of chronic hepatitis B (CHB) is unclear. Aim: We aimed to study the relationship between metabolic syndrome and the risk of liver cirrhosis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics